I can provide some national perspective. You will probably be aware that in November 2018 the licensing boards had to publish their new licensing policy statements, which AFS reviewed to see whether there are any emerging national trends, examples of good practice or areas of continuing challenge.
There is some good news. We can see measures to promote the health objective in every policy statement, to varying extents—we can identify that with different levels of ease. However, dealing with overprovision remains one of the main ways in which boards seek to promote public health. Of the 38 published policies, 15 boards found some extent of overprovision, 20 boards found no overprovision, and a couple were still consulting on that aspect of the policy. On the changes from the previous statements, there were a handful of areas where overprovision had increased and a handful where it had decreased, but the vast majority of boards have retained their existing policies.
What really stands out is that boards are approaching their assessments of overprovision very differently, and they are applying very different standards of proof. This is where the situation gets a bit abstract and hard to explain. In some areas, boards almost interpret the need to demonstrate a causal link as meaning that they have to prove definitively that X equals or will cause Y. In other areas, boards believe that they need to show that it is more likely than not that X causes Y, so they go more by the balance of probabilities.
I can give you some examples of what boards have said. In a couple of areas, they reported that they could not establish a causal link because the harm that they had identified as resulting from alcohol was not the direct and sole consequence of the number of premises. In the real world, it would be impossible to prove that the harm identified was the direct and sole consequence of the number of premises. There are so many compounding factors in real life that we could never control.
In other areas, boards have said that they can see evidence of a correlation between harm and the number of premises, but that evidence falls short of meeting the causal test required by law. The question remains: what level of evidence is required to justify a finding of overprovision? When does the balance of probabilities tip in favour of something being causal as opposed to correlational?
It is really hard to link harm to specific premises, because people travel to purchase alcohol. We have seen a rise in online sales, which can be really challenging. Also in the mix is the fact that we do not have sales data—we do not know where people are buying their alcohol, or how much they are buying. However, having highlighted those challenges, I note that a large number of boards are very confident. They have looked at the evidence and have created robust policy based on the balance of probabilities.
The review of policy shows that there is real inconsistency. I go back to Annabelle Ewing’s comments about promoting the good practice and providing boards with a bit more guidance and support. I will bring up Glasgow again—I am sorry; this keeps coming back to Mairi Millar—where a really promising new approach was adopted. The board there said that in areas that experience really high levels of harm, it will still reserve the right to refuse additional off-licences, because the evidence that it has gathered identified that if an area was already experiencing harm, throwing extra off-sales availability into the mix was likely to make the problem worse. That is a promising bit of good practice, because, to an extent, it detaches the health objective from overprovision and shifts the focus from the number of premises to the question of the harm that communities experience. We should be supporting and strengthening boards and getting them to share that practice, which might counter a lot of the problems that are being experienced.